p21, p53, and p27 Kip1 alterations in benign and malignant tumors of sinonasal epithelium

Otolaryngology - Head and Neck Surgery

Volumn 129, Issue 1, 2003, Pages 77-84

  Keleş, Nesil ^a   Erdamar, Burak ^b   Kaur, Ahmet ^b   Deǧer, Kemal ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; PROTEIN P27; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BENIGN TUMOR; CANCER GRADING; CELL CYCLE; CELL KINETICS; CELL PROLIFERATION; CLINICAL ARTICLE; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVERTED PAPILLOMA; KERATINIZATION; MALIGNANT NEOPLASTIC DISEASE; NOSE TUMOR; PARANASAL SINUS TUMOR; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; COHORT ANALYSIS; GENETICS; SURGERY;

CELL CYCLE PROTEINS; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; HUMANS; NOSE NEOPLASMS; PAPILLOMA, INVERTED; PARANASAL SINUS NEOPLASMS; SURGICAL PROCEDURES, OPERATIVE; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0042786629     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0194-5998(03)00520-5     Document Type: Article

References (19)

1. Mirza N, Montone K, Sato Y, et al. Identification of p53 and human papilloma virus in Schneiderian papillomas. Laryngoscope 1998;108:497-501.
2. Caruana SM, Zwiebel N, Cocker R, et al. p53 alteration and human papilloma virus infection in paranasal sinus cancer. Cancer 1997;79:1320-8.
3. Lawson W, Ho BT, Shaari CM, et al. Inverted papilloma: a report of 112 cases. Laryngoscope 1995;105:282-8.
4. Furata Y, Shinohara T, Sano K, et al. Molecular pathologic study of human papilloma virus infection in inverted papilloma squamous cell carcinomas of the nasal cavities and paranasal sinuses. Laryngoscope 1991;101:79-85.
5. Weber RS, Shillitoe EJ, Robbins KT, et al. Prevalence of human papilloma virus in inverted papilloma. Arch Otolaryngol Head Neck Surg 1988;114:23-6.
6. Syrjanen S, Happonen RP, Virolainen E, et al. Detection of human papilloma virus (HPV) structural antigens and DNA types in inverted papillomas and squamous cell carcinomas of the nasal cavities and paranasal sinuses. Acta Otolaryngol (Stockh) 1987;104:334-41.
7. Nadal A, Jares P, Cazorla M, et al. p21 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx. J Pathol 1997;183:156-63.
8. Saegusa M, Nitta H, Hashimura M, et al. Down-regulation of p27 expression is correlated with increased cell proliferation but not expression of p21 and p53, and human papilloma virus infection in benign and malignant tumors of sinonasal regions. Histopathology 1999;35:55-64.
9. Komiya T, Hosona Y, Hirashima T, et al. p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung. Clin Cancer Res 1997;3:1831-35.
10. Tsihlias J, Kapusta LR, DeBoer G, et al. Loss of cyclin-dependent kinase inhibitor p27 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 1998;58:542-8.
11. Jeanon JP, Soames J, Lunec J, et al. Expression of cyclin-dependent kinase inhibitor p21 and p53 tumor suppressor gene in laryngeal cancer. Clin Otolaryngol 2000;25:23-7.
12. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependant kinase inhibitor p27 aggressive colorectal carcinoma. Nat Med 1997;3:231-4.
13. Sheaff RJ, Groudine M, Gordon M, et al. Cyclin E-CDK2 is a regulator of p27 KIP-1. Genes Dev 1997;11:1464-78.
14. Lloyd RV, Jin L, Qian X, et al. Aberrant p27 kip1 expression in endocrine and other tumors. Am J Pathol 1997;150:401-7.
15. Catzavelos GC, Bhattacharya N, Ung YC, et al. Decreased levels of the cell-cycle inhibitor p27 kip1 protein: prognostic implications in primary breast cancer. Nat Med 1997;3:227-30.
16. Mori M, Mimori K, Shiraishi T, et al. p27 expression and gastric carcinoma. Nat Med 1997;3:593-7.
17. Jordan RCK, Bradley. Reduced levels of the cell-cycle inhibitor p27 in epithelial dysplasia and carcinoma of the oral cavity. Am J Pathol 1998;152:585-90.
18. Pruneri G, Pignataro L, Carboni N, et al. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer. J Clin Oncol 1999;17:3150-9.
19. Cruz IB, Snijders PJF, Meijer CJ, et al. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 1998;184:360-8.